← Back to Search

Radiation

Hypofractionated Whole Breast Radiation Therapy for Breast Carcinoma

N/A
Waitlist Available
Led By Afshin Forouzannia, M.D.
Research Sponsored by St. Joseph Hospital of Orange
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial is testing whether a combined schedule of radiation therapy is superior to the standard schedule in terms of local control and cosmetic outcome.

Eligible Conditions
  • Breast Carcinoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assessment of acute and late toxicity
Secondary outcome measures
Cosmetic Evaluation
Disease Free Survival
Overall Survival

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intraoperative Electron Radiation TherapyExperimental Treatment2 Interventions
A single dose of electron irradiation given at the surgical site during the operation to remove the cancerous tumor will replace the usual 5-8 days of localized radiation. Hypofractionated Whole Breast Radiation Therapy must start within 14-56 days post operatively.

Find a Location

Who is running the clinical trial?

St. Joseph Hospital of OrangeLead Sponsor
9 Previous Clinical Trials
864,883 Total Patients Enrolled
Afshin Forouzannia, M.D.Principal InvestigatorThe Center for Cancer Prevention & Treatment at St. Joseph Hospital of Orange

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~14 spots leftby Apr 2025